We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




DNA Fingerprinting Tracks Global Path of Plague Pathogen

By LabMedica International staff writers
Posted on 06 Dec 2010
Print article
An international team of scientists has traced major plague pandemics such as the Black Death back to their origins utilizing DNA fingerprinting analysis.

Researchers from Ireland, China, France, Germany, and the United States, including Northern Arizona University's (NAU) Drs. Paul Keim and David Wagner examined the past 10,000 years of global plague disease events.

Their findings regarding the plague pathogen, Yersinia pestis, will be published in an upcoming issue of the journal Nature Genetics. Dr. Keim, director of NAU's Center for Microbial Genetics and Genomics (Flagstaff, AZ, USA) and division director of Translational Genomics Research Institute, reported that while the plague is less of a threat to humans than at other times in history, such as the Middle Ages, the current plague research could be applied to ongoing health threats around the world.

This type of DNA fingerprinting can be used to characterize both natural and nefarious plague outbreaks, which is crucial when a bacterium is used as a biologic weapon. "This work is more of a model for our control of epidemic diseases such as Salmonella, E. coli and influenza,” Dr. Keim said. "Plague took advantage of human commercial traffic on a global scale, just as the flu and food-borne diseases do today. Future epidemiologists can learn from this millennium-scale reconstruction of a devastating disease to prevent or control future infectious disease outbreaks.”

Tracing the worldwide spread of plague required identifying mutations in as many strains as possible. However, transferring live bacterium across country boundaries is very regulated and difficult due to its potential danger, presenting a hurdle for scientists.

To make this research achievable, the team designed an innovative strategy of decentralized experiments where scientists in worldwide locations worked with one or several of 17 complete plague whole genome sequences. By electronically combining all of the research data, the team identified hundreds of variable sites in the DNA while gathering one of the largest dispersed global collections of plague isolates. That information was used to reconstruct the spread of plague pandemics, calculate the age of different waves of outbreak, and was linked to descriptions in the historic record to better clarify the current existence of plague.

The results serve as a map of how the plague made its way around the globe. Their collaborative research determined that the plague pathogen originated in or near China where it has evolved and emerged multiple times to cause global pandemics. The international team of investigators also identified unique mutations in country-specific plague lineages.

Tracing its evolution, the plague spread over various historic trade routes as early as the 15th century. Chinese admiral and explorer Zheng He's travels may have taken the plague to central Africa. The Silk Road, which led from China to Western Asia and on to Europe also may have served as an avenue for disease. The latest plague pandemic of the late 1800s persists today in wild rodents throughout the western United States.

"The plague found its way to the United States in the late 19th and early 20th century through multiple port cities by infected ship-borne rats,” said Dr. Wagner, assistant professor of biological sciences at NAU. "Based upon DNA variation detected from these comparisons, we determined that the original plague strains that infected the US had their origin in Asia and likely made their way to California via Hawaii.”

While plague pandemics are something of the past, the disease has never fully disappeared. The bacterium remains ecologically established in animal populations worldwide, and has resurfaced in Africa and Madagascar.

"This study gives one the exciting feeling that we are able to rewind time,” said Elisabeth Carniel, director of the National Reference Laboratory and World Health Organization Collaborating Center for Yersinia at the Institut Pasteur (Paris, France). "However, this should not lead us to consider plague a disease of the past. We are observing its re-emergence in countries where it has been silent for decades. Therefore, far from being extinct, plague is a reemerging disease.”

Related Links:
Northern Arizona University's Center for Microbial Genetics and Genomics


New
Gold Member
ANA & ENA Screening Assays
ANA and ENA Assays
Automated Blood Typing System
IH-500 NEXT
New
Monkeypox Test
Monkeypox Virus Rapid Antibody Test
New
Adenovirus Detection Kit
REALQUALITY RQ-ADENO

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more

Pathology

view channel
Image: The artificial intelligence models can personalize immune therapies in oncology patients (Photo courtesy of 123RF)

AI Tool Identifies Novel Genetic Signatures to Personalize Cancer Therapies

Lung cancer and bladder cancer are among the most commonly diagnosed cancers globally. Researchers have now developed artificial intelligence (AI) models designed to personalize immune therapies for oncology... Read more

Technology

view channel
Image: Schematic diagram of nanomaterial-based anti-epileptic drug concentration diagnostic technology (Photo courtesy of KRISS)

Nanomaterial-Based Diagnostic Technology Accurately Monitors Drug Therapy in Epilepsy Patients

Many patients with epilepsy take anti-epileptic drugs to control frequent seizures in their daily lives. To optimize treatment and avoid side effects from overdosing, it is crucial for patients to regularly... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.